Details for Patent: 7,998,108

Which drugs does patent 7,998,108 protect, and when does it expire?

Patent 7,998,108 protects YUTIQ and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 7,998,108

Title:	Injector apparatus and method of use
Abstract:	Disclosed herein is an injector device including an inserter element, a head element, an implant and a set of detachable protector elements for secured device handling. The device comprises a stop that controls the penetration depth of the device during injection. The device may comprise a removable catch that prevents the implant from exiting the device due to the advancement of its inserter element. The device may comprise a disengageable block that prevents the implant from exiting the device from its head element. The device may be configured for intraocular drug delivery.
Inventor(s):	Nazzaro; Martin (Quincy, MA), Guo; Hong (Belmont, MA), LeBlanc; Ron (Hopedale, MA), York; Josh (Ipswich, MA)
Assignee:	pSivida US, Inc. (Watertown, MA)
Application Number:	11/900,907
Patent Claim Types: see list of patent claims	Use; Device; Dosage form;

Drugs Protected by US Patent 7,998,108

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alimera Sciences Inc	YUTIQ	fluocinolone acetonide	IMPLANT;INTRAVITREAL	210331-001	Oct 12, 2018		RX	Yes	Yes			Y			A METHOD OF INJECTING AN IMPLANT

International Family Members for US Patent 7,998,108

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2008033426